Transcript get slides

December 2016 CardioLAN Webinar Course
Cholesterol:
The Good, The Bad & The Ugly
Guest Expert:
Chelsea E. Leonard
PharmD, Clinical Pharmacist
This material was prepared by Quality Insights, the Medicare Quality Innovation Network-Quality
Improvement Organization supporting the Home Health Quality Improvement National Campaign, under
contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health
and Human Services. The views presented do not necessarily reflect CMS policy. Publication number 11SOW-WV-HH-MMD-111516A
Continuing Education Credits
 Nursing: 1.25 hrs of Continuing Education
– Approved by the Alabama State Nurses
Association, an accredited approver by
the American Nurses Credentialing
Center’s Commission on Accreditation
HHQI Announcements
My HHQI Blog
 Learn About Cholesterol: The Good, the Bad,
and the Ugly (9/16/16)
– Chelsea E. Leonard, PharmD, Clinical Pharmacist
– Frances V. Cohenour, PharmD, Clinical Pharmacist
& Co-Owner
– Chad’s Payless Pharmacy (Florence, Alabama)
Cholesterol: The
Good, The Bad,
and The Ugly
CHELSEA E. LEONARD, PHARMD
Disclosure

I do not have (nor does any immediate family
member have) actual or potential conflict of
interest, within the last twelve months, a vested
interest in or affiliation with any corporate
organization offering financial support or grant
monies for this continuing education activity, or
any affiliation with an organization whose
philosophy could potentially bias this
presentation.
Objectives





Differentiate between the different types of
cholesterol
Identify the treatment guidelines for cholesterol
management
Explain to patients about lifestyle modifications that
can improve cholesterol management
Describe over-the-counter medications that can be
used to improve cholesterol management
Identify ways to involve community pharmacists in
managing cholesterol
Get the Facts

73.5 million adults in the United States have high LDL

People with high cholesterol have twice the risk of
heart disease


Heart disease is the leading cause of death in the United
States

Other risk factors include: diabetes, obesity, poor diet,
physical inactivity, excessive alcohol intake
Less than half of adults with high cholesterol get
treatment
Center for Disease Control. High Cholesterol Facts. 2015
Heart Disease Heath Rates
Center for Disease Control. Heart Disease Fact Sheet. 2016.
What is Cholesterol?



Waxy, fat-like substance that travels through
the blood attached to proteins called
lipoproteins
Two sources:

Produced in the body to make certain hormones

Food (eggs, cheese, fatty meats, etc.)
Build up of cholesterol can cause plaques in
arteries
Center for Disease Control. About High Cholesterol. 2015
Cholesterol Sources
Cholesterol Panel


HDL – “good” cholesterol

Absorbs bad cholesterol and takes it back to the liver to be
flushed out of the body

Can reduce the risk of heart disease and stroke

Ideal level: 40 mg/dL or higher
LDL – “bad” cholesterol

Makes up the majority of body’s cholesterol

High levels can cause plaque buildup in arteries and lead to
heart disease and stroke

Ideal level: less than 100 mg/dL
Center for Disease Control. LDL and HDL: “Bad” and “Good” Cholesterol. 2015
Cholesterol Panel (cont.)


Triglycerides – “ugly” cholesterol

Type of fat found in blood

When combined with high LDL or low HDL, the risk of
heart attack or stroke is increased

Affected by eating fatty foods, refined sugars,
carbohydrates

Ideal level: less than 150 mg/dL
Total cholesterol

Ideal level: less than 200 mg/dL
Center for Disease Control. LDL and HDL: “Bad” and “Good” Cholesterol. 2015
Triglycerides
Cholesterol Screening
 Fasting
full lipid panel
 Recommended
years old
 Should
years
for adults over 20
be checked at least every 5
Center for Disease Control. LDL and HDL: “Bad” and “Good” Cholesterol. 2015
Fasting Lipid Panel

At least 8 hours with no food or drink (except water or
black coffee)

If not:
Polling Question #1

What is the ideal level of total cholesterol?
A.
<150 mg/dL
B.
<175 mg/dL
C.
<200 mg/dL
D.
<250 mg/dL
Treatment
Guidelines
and
Medications
Treatment Guidelines Definitions

Atherosclerotic cardiovascular disease
(ASCVD)


Acute coronary syndromes, MI, stable or unstable
angina, coronary or other arterial revascularization,
stroke or TIA, PAD
ASCVD outcomes

MI, stroke, ASCVD death

Treatment guidelines aiming to prevent these
outcomes
Stone N J et al. Circulation. 2013.
Treatment Guidelines –
Statin Benefit Groups
Clinical
ASCVD
LDL >
190
Diabetes
10-yr risk
≥ 7.5%
Stone N J et al. Circulation. 2013.
ASCVD Risk

10-yr risk estimate based on:
•
•
•
•
•
Gender
Age
Race
Total cholesterol
HDL
•
•
•
•
Smoking status
Diabetes
Hypertension
Systolic Blood Pressure
ASCVD Risk Estimator can be found here:
http://tools.acc.org/ASCVD-Risk-Estimator
Stone N J et al. Circulation. 2013.
Statin Medications
Atorvastatin
(Lipitor)
Rosuvastatin
(Crestor)
Simvastatin
(Zocor)
Lovastatin
(Mevacor)
Pitavastatin
(Livalo)
Fluvastatin
(Lescol)
Statin Medications

Work in liver to prevent formation of cholesterol, thus
decreasing amount of cholesterol in the blood

Most potent total cholesterol and LDL-lowering
agents

Cholesterol-independent effects:

Increase stability of atherosclerotic plaques

Decrease inflammation

Inhibit thrombogenic response
Atorvastatin. Lexicomp Online® Lexi-Drugs.®
Treatment
Guidelines
Stone N J et al. Circulation. 2013.
Statin Intensity
High Intensity (lowers
LDL ≥ 50%)
•Atorvastatin 40 or 80
mg
•Rosuvastatin 20 or 40
mg
Moderate Intensity
(lowers LDL 30-50%)
•Atorvastatin 10 or 20
mg
•Rosuvastatin 5 or 10
mg
•Simvastatin 20 or 40
mg
•Pravastatin 40 or 80
mg
•Lovastatin 40 mg
•Fluvastatin XL 80 mg
•Fluvastatin 40 mg BID
•Pitavastatin 2 or 4 mg
Low Intensity (lowers
LDL <30%)
•Simvastatin 10 mg
•Pravastatin 10 or 20
mg
•Lovastatin 20 mg
•Fluvastatin 20 or 40 mg
•Pitavastatin 1 mg
Stone N J et al. Circulation. 2013.
Statin Medications

Dosed once daily in the evening


Atorvastatin, rosuvastatin, and pitavastatin can be
given any time during the day
Most common side effect reported is muscle
symptoms

Cramps, pain, weakness, etc.

Women have higher risk of muscle symptoms

If symptoms become problematic, dose of current
statin should be lowered or patient should be switched
to a different statin
Atorvastatin. Lexicomp Online® Lexi-Drugs.®
Statin Medications

Significant drug interactions:

Amiodarone

Azole antifungals (fluconazole, ketoconazole, etc.)

Calcium channel blockers (amlodipine, diltiazem, etc.)

Cimetidine

Colchicine

Digoxin

Warfarin

Grapefruit juice
Atorvastatin. Lexicomp Online® Lexi-Drugs.®
Non-Statin Medications
Bile acid
sequestrants
• Cholestyramine (Questran), colestipol
(Colestid), colesevelam (Welchol)
Fibric acid
derivatives
• Fenofibrate (TriCor), gemfibrozil (Lopid)
Cholesterol• Ezetimibe (Zetia)
absorption inhibitors
Niacin
• Immediate-release and extendedrelease (Rx only)
Bile Acid Sequestrants



Can lower LDL by 15-30%
Useful when patient also has diabetes
Gastrointestinal side effects



Constipation, bloating, belching
Must be titrated over a few months to avoid GI upset
Other tips:

Separate from other medications – give either 1 hour before or 4
hours after other mediations

Give with lots of water

Increase fiber intake
Cholestyramine. Lexicomp Online® Lexi-Drugs.®
Fibric Acid Derivatives

Can increase HDL and decrease triglycerides

Side effects:


Combination with statins increases risk of
myalgia/myopathy


Nausea, vomiting, diarrhea, abdominal pain
Avoid gemfibrozil with simvastatin or lovastatin
Other tips:

Gemfibrozil should be given 30 minutes before meals
Gemfibrozil. Lexicomp Online® Lexi-Drugs.®
Cholesterol Absorption Inhibitor
 Decreases
 Mild
LDL by ~17%
side effects
 Increased
LFTs – should be monitored
periodically
 Other
 Can
tips:
be given with or without food
Ezetimibe. Lexicomp Online® Lexi-Drugs.®
Niacin

Decreases LDL, increases HDL, decreases triglycerides

Most common side effects: flushing and itching

Can give 325 mg aspirin 30 minutes before niacin

Avoid spicy foods and hot beverages

Extended-release formulation (Rx only) can also reduce flushing

Combination with statin may increase risk of myalgia/myopathy

Other tips:

Give with food to reduce GI side effects

“No flush” formulations should be avoided as they do not affect lipids
Niacin. Lexicomp Online® Lexi-Drugs.®
Polling Question #2

Which class of medications does NOT decrease
LDL?
A.
Fibric Acid Derivatives
B.
Statins
C.
Bile Acid Sequestrants
D.
Cholesterol Absorption Inhibitors
Lifestyle
Modifications
Lifestyle Modifications

Recommended as background therapy
for ALL patients

Typically implemented for six months
prior to starting medications

Should not be stopped when
medications are introduced
Lifestyle Modifications


Heart healthy diet

Low fat, high fiber

American Heart Association recommends DASH
diet (low sodium, low saturated fat)
Regular exercise



At least 40 minutes three to four days per week
Avoidance of tobacco products
Maintenance of a healthy weight
American Heart Association. Lifestyle Changes and Cholesterol. 2016.
Over-the-Counter
Supplementation
Coenzyme Q10 (CoQ10)
Demonstrated some benefit in reducing
muscle symptoms from statins
 Dosing: 300 mg per day
 Inexpensive
 Low-risk
 Should not be taken if patient is on a
blood thinner like warfarin

Ubiquinone. Lexicomp Online® Natural Products Database. 2016
Omega-3 Fish Oil

Can decrease triglycerides and increase HDL

Dosing: 2-4 grams per day

Most common side effect: fishy aftertaste

Enteric coated formulation helps reduce risk of fishy
taste

Can also freeze capsules or take with a meal to avoid

Should not be taken if patient is on a blood
thinner like warfarin

Omega-3 also found in flaxseed, chia seeds,
walnuts, seafood, soybeans, spinach, etc.
Omega-3 Fatty Acids. Lexicomp Online® Lexi-Drugs.® 2016.
Red Yeast Rice

Considered the “natural statin”

Contains monacolin K – chemically identical to
active ingredient in lovastatin

Dosing: 1,200mg twice daily

Side effects similar to statins

Should not be used while pregnant or breastfeeding

Many drug interactions

May be useful if patient is unable to tolerate statin
Red Yeast Rice. Lexicomp Online® Natural Products Database. 2016
Red Wine



Key ingredient - resveratrol

May increase HDL and protect against plaque buildup

May help protect the lining of blood vessels in heart
A drink is defined as 5 ounces of wine

Women: one drink per day

Men > 65: one drink per day

Men < 65: two drinks per day
Resveratrol is also found in red/purple grapes,
peanuts, blueberries, and cranberries – may not be
as beneficial
Mayo Clinic. Red wine and resveratrol: Good for your heart? 2016.
How to
Involve Your
Community
Pharmacist
Polling Question #3

Do you have a community pharmacist you
communicate with regularly?
A.
Yes
B.
No
Adherence

Medications are not effective unless
taken properly

Common adherence issues:
 Cost
 Pill
burden
 Forgetfulness
 Side
effects
Side Effect Management

Common reason for adherence issues

Side effects could be reduced by taking
medication with food, at a different time of day,
etc.

Dosage may be too high and pharmacist can
communicate with prescriber to make
recommendations

Pharmacist can recommend OTC agents to help
with side effects (ex. CoQ10 for muscle cramps)
Drug Interactions

Pharmacist can identify drug
interactions and communicate with
prescriber if action needs to be taken

Pharmacists can determine if
interactions can be prevented if the
medications are separated
Point-of-Care Testing

Many pharmacists have the capability to
check cholesterol in the pharmacy

Can provide results in approximately 5 minutes
and make recommendations for
management
New updates?
New Statin Recommendations

US Preventive Services Task Force released new
recommendations in November

Recommends that all patients 40 years and older
should be screened to see if they need a statin
regardless of history of cardiovascular disease

Risk factors:

High cholesterol

High blood pressure

Diabetes

smoking
United States Preventive Services Task Force. Statin Use for the Primary
Prevention of Cardiovascular Disease in Adults: Preventive Medication. 2016.
Chelsea E. Leonard, PharmD
Chad’s Payless Pharmacy, Inc.
Florence, AL
Questions?
[email protected]
256.766.3298
References

Center for Disease Control. High Cholesterol Facts.
2015. Available at:
http://www.cdc.gov/cholesterol/facts.htm

Center for Disease Control. Heart Disease Fact Sheet.
2016. Available at:
http://www.cdc.gov/dhdsp/data_statistics/fact_sheets
/fs_heart_disease.htm

Center for Disease Control. About High Cholesterol.
2015. Available at:
http://www.cdc.gov/cholesterol/about.htm.

Center for Disease Control. LDL and HDL: “Bad” and
“Good” Cholesterol. 2015. Available at:
http://www.cdc.gov/cholesterol/ldl_hdl.htm
References (cont.)

Stone, NJ, et al. 2013 ACC/AHA Guideline on the
Treatment of Blood Cholesterol to Reduce
Atherosclerotic Cardiovascular Risk in Adults.
Circulation. 2013;01.cir.0000437738.63853.7a, originally
published November 12, 2013.

Atorvastatin. Lexicomp Online® Lexi-Drugs® , Hudson,
Ohio: Lexi-Comp, Inc.; November 2, 2016.

Cholestyramine. Lexicomp Online® Lexi-Drugs® ,
Hudson, Ohio: Lexi-Comp, Inc.; November 2, 2016.

Gemfibrozil. Lexicomp Online® Lexi-Drugs® , Hudson,
Ohio: Lexi-Comp, Inc.; November 2, 2016.

Ezetimibe. Lexicomp Online® Lexi-Drugs® , Hudson,
Ohio: Lexi-Comp, Inc.; November 2, 2016.
References (cont.)

Niacin. Lexicomp Online® Lexi-Drugs® , Hudson, Ohio:
Lexi-Comp, Inc.; November 2, 2016.

American Heart Association. Lifestyle Changes and
Cholesterol. 2016. Available at:
https://www.heart.org/HEARTORG/Conditions/Choleste
rol/PreventionTreatmentofHighCholesterol/LifestyleChanges-and-Cholesterol_UCM_305627_Article.jsp#

Ubiquinone. Lexicomp Online® Natural Products
Database , Hudson, Ohio: Lexi-Comp, Inc.; November
2, 2016.

Omega-3 Fatty Acids. Lexicomp Online® Lexi-Drugs® ,
Hudson, Ohio: Lexi-Comp, Inc.; November 2, 2016.
References (cont.)

Red Yeast Rice. Lexicomp Online® Natural Products
Database , Hudson, Ohio: Lexi-Comp, Inc.; November
2, 2016.

Mayo Clinic. Red wine and resveratrol: Good for your
heart? 2016. Available at:
http://www.mayoclinic.org/diseases-conditions/heartdisease/in-depth/red-wine/art-20048281

United States Preventive Services Task Force. Statin Use
for the Primary Prevention of Cardiovascular Disease in
Adults: Preventive Medication. 2016. Available at:
https://www.uspreventiveservicestaskforce.org/Page/D
ocument/UpdateSummaryFinal/statin-use-in-adultspreventive-medication1.
Questions?
HHQI Cholesterol Resources
 Cholesterol management
& Smoking cessation Best
Practice Intervention
Package (BPIP)
– Current American College of
Cardiology/American Heart
Association (ACC/AHA)
guidelines
– Clinician & Patient tools
Patient Tools
Patient Tools (cont.)
Medication Adherence Assessment
 HHQI Underserved
Population BPIP
– Morisky Medication
Adherence Scale & Tip
Sheet
 HHQI Medication
Management Focused
BPIP
– Guiding Patients Toward
Medication Adherence
Continuing Education Steps
Follow these steps to get your CE certificate:
1. Register/log in to HHQI University. You will be automatically
redirected to this website when you exit this webinar.
Continuing Education Steps
2. Click on the Cholesterol: The Good, the Bad, and
the Ugly course in the Cardiovascular
Health course catalog.
3. Click on Enroll under the
icon.
4. Click on My Account
to launch the course.
5. Click on the
icon next to the course in the
View column.
Continuing Education Steps
6. Click on the
to Lesson 1.
icon in the Action column next
• Complete the reflective question and evaluation
7. After completing the evaluation, you can print your
certificate from the My Account area in HHQI
University.
Questions?
Thank You!
[email protected]
www.HomeHealthQuality.org
This material was prepared by Quality Insights, the Medicare Quality Innovation Network-Quality Improvement Organization supporting the Home Health
Quality Improvement National Campaign, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of
Health and Human Services. The views presented do not necessarily reflect CMS policy. Publication number 11SOW-WV-HH-MMD-111516A